131I-MIP-1095 Uses, Dosage, Side Effects and more
131I-MIP-1095 is under investigation in clinical trial NCT03030885 (Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)).
| Trade Name | 131I-MIP-1095 |
| Generic | MIP-1095 I-131 |
| MIP-1095 I-131 Other Names | 131I-MIP-1095 |
| Type | |
| Formula | C19H25IN4O8 |
| Weight | Average: 568.335 Monoisotopic: 568.073362949 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
